HUE043088T2 - Halikondrin B analógok szintézisében alkalmazható eljárások - Google Patents

Halikondrin B analógok szintézisében alkalmazható eljárások

Info

Publication number
HUE043088T2
HUE043088T2 HUE14866945A HUE14866945A HUE043088T2 HU E043088 T2 HUE043088 T2 HU E043088T2 HU E14866945 A HUE14866945 A HU E14866945A HU E14866945 A HUE14866945 A HU E14866945A HU E043088 T2 HUE043088 T2 HU E043088T2
Authority
HU
Hungary
Prior art keywords
halicondrin
analogs
synthesis
methods
Prior art date
Application number
HUE14866945A
Other languages
English (en)
Hungarian (hu)
Inventor
Bryan Lewis
Yongbo Hu
Huiming Zhang
Hiroyuki Chiba
Yuki Komatsu
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of HUE043088T2 publication Critical patent/HUE043088T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HUE14866945A 2013-12-06 2014-12-05 Halikondrin B analógok szintézisében alkalmazható eljárások HUE043088T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361912714P 2013-12-06 2013-12-06

Publications (1)

Publication Number Publication Date
HUE043088T2 true HUE043088T2 (hu) 2019-08-28

Family

ID=53270478

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14866945A HUE043088T2 (hu) 2013-12-06 2014-12-05 Halikondrin B analógok szintézisében alkalmazható eljárások

Country Status (13)

Country Link
US (4) US9303039B2 (https=)
EP (2) EP3077399B1 (https=)
JP (3) JP6443812B2 (https=)
CN (1) CN105916861B (https=)
BR (1) BR112016012237B1 (https=)
CA (1) CA2931788C (https=)
ES (1) ES2723355T3 (https=)
HU (1) HUE043088T2 (https=)
IL (4) IL245661A0 (https=)
MX (3) MX384292B (https=)
RU (1) RU2676486C1 (https=)
SG (2) SG11201604545XA (https=)
WO (1) WO2015085193A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2522663B1 (en) 2004-06-03 2015-04-01 Eisai R&D Management Co., Ltd. Intermediates for the preparation of halichondrin B
RU2489437C2 (ru) 2007-10-03 2013-08-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Промежуточные соединения и способы синтеза аналогов галихондрина в
CN105801599A (zh) 2008-04-04 2016-07-27 卫材R&D管理有限公司 软海绵素b类似物
WO2011094339A1 (en) 2010-01-26 2011-08-04 Eisai R&D Management Co., Ltd. Furo [3, 2 -b] pyrane derivatives useful in the synthesis of halichondrin b analogs
EP3689881B1 (en) * 2013-11-04 2022-01-12 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b
MX384292B (es) * 2013-12-06 2025-03-14 Eisai R&D Man Co Ltd Metodos utiles en la sintesis de analogos de halicondrina b.
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
KR102743950B1 (ko) 2015-05-07 2024-12-18 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 마크롤라이드의 합성에 유용한 마크로고리화 반응 및 중간체 및 기타 단편
EP3413887B1 (en) * 2016-02-12 2021-04-07 Eisai R&D Management Co., Ltd. Intermediates in the synthesis of eribulin and related methods of synthesis
EP3423105B1 (en) 2016-03-02 2021-05-05 Eisai R&D Management Co., Ltd. Eribulin-based antibody-drug conjugates and methods of use
US11136335B2 (en) 2016-06-30 2021-10-05 Eisai R&D Management Co., Ltd. Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
ES2931533T3 (es) * 2017-04-05 2022-12-30 Harvard College Compuesto macrocíclico y usos del mismo
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
WO2018217894A1 (en) * 2017-05-24 2018-11-29 Eisai R&D Management Co., Ltd. Fluorine-labelled halichondrin derivatives and related methods of synthesis
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
HUE061306T2 (hu) 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise
CN109694379B (zh) * 2017-10-24 2020-09-11 江苏恒瑞医药股份有限公司 用于制备艾日布林的中间体及其制备方法
CN111566113B (zh) 2017-11-15 2024-01-09 哈佛大学的校长及成员们 大环化合物及其用途
US11419856B2 (en) 2017-11-20 2022-08-23 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of neoplastic diseases
SG11202005548WA (en) 2018-01-03 2020-07-29 Eisai R&D Man Co Ltd Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof
JP2021532102A (ja) * 2018-07-20 2021-11-25 ドクター レディズ ラボラトリーズ リミテッド エリブリンおよびその中間体の調製のための精製プロセス
EP3864011A4 (en) * 2018-10-09 2022-06-29 Dr. Reddy's Laboratories Ltd. Process for preparation of eribulin and intermediates thereof
US12522611B2 (en) * 2018-11-28 2026-01-13 Natco Pharma Limited Process for the preparation of high pure Eribulin and its Mesylate salt
US11447499B2 (en) 2019-06-14 2022-09-20 Rk Pharma Inc. Process for the preparation of eribulin mesylate intermediate
WO2022101931A1 (en) * 2020-11-10 2022-05-19 Natco Pharma Limited Process for the preparation of eribulin and its intermediates
CN113354659B (zh) * 2021-06-08 2022-04-08 江苏慧聚药业股份有限公司 甲磺酸艾日布林的合成
CN114380840B (zh) * 2022-01-27 2024-01-26 江苏慧聚药业股份有限公司 艾日布林的合成
WO2025106586A1 (en) * 2023-11-13 2025-05-22 Luxvitae Therapeutics Inc. Macrocyclic ketone compounds and applications thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU652180A1 (ru) 1975-12-16 1979-03-15 Краснодарский политехнический институт 1(Фурил-2,)-2-(2-,, формилфурил-5,, ) этилен или его метильное производное как промежуточный продукт дл синтеза фуран-2,5-дикарбоновой кислоты и способ его получени
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
TW255880B (https=) 1992-09-09 1995-09-01 Hoechst Ag
WO1998009942A1 (en) 1996-09-06 1998-03-12 Eli Lilly And Company Catalytic selective sulfonylation process
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
US6214865B1 (en) 1998-06-17 2001-04-10 Eisai Co., Ltd. Macrocyclic analogs and methods of their use and preparation
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
CA2822994C (en) * 2004-06-03 2016-09-27 Eisai R&D Management Co., Ltd. Intermediates for the preparation of analogs of halichondrin b
EP2522663B1 (en) 2004-06-03 2015-04-01 Eisai R&D Management Co., Ltd. Intermediates for the preparation of halichondrin B
US20060045846A1 (en) 2004-08-30 2006-03-02 Horstmann Thomas E Reagents and methods for labeling terminal olefins
EP1831697A4 (en) 2004-12-09 2011-01-26 Eisai R&D Man Co Ltd SEARCH FOR TUBULINISOTYPES IN CANCER THERAPY USING HALICHONDRIN B ANALOG
WO2008010776A1 (en) 2006-07-21 2008-01-24 Agency For Science, Technology And Research Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection
JPWO2009014105A1 (ja) 2007-07-20 2010-10-07 株式会社山田養蜂場本社 新規カルボン酸およびそれを有効成分とする抗うつ用組成物
RU2489437C2 (ru) 2007-10-03 2013-08-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Промежуточные соединения и способы синтеза аналогов галихондрина в
RU2010118063A (ru) 2007-11-16 2011-12-27 ЭЙСАЙ Ар энд Ди МЕНЕДЖМЕНТ КО., ЛТД. (JP) Новое промежуточное соединение для синтеза аналога галихондрина в и новая реакция десульфонилирования, применяемая для получения промежуточного соединения
CN105801599A (zh) 2008-04-04 2016-07-27 卫材R&D管理有限公司 软海绵素b类似物
JP5371091B2 (ja) 2009-01-23 2013-12-18 三菱レイヨン株式会社 モノスルホン酸エステルの製造方法
WO2011094339A1 (en) 2010-01-26 2011-08-04 Eisai R&D Management Co., Ltd. Furo [3, 2 -b] pyrane derivatives useful in the synthesis of halichondrin b analogs
EP2354128A1 (en) 2010-02-10 2011-08-10 Sandoz Ag Method for the preparation of rivaroxaban
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
EP2785687B1 (en) 2011-11-30 2019-02-20 Sandoz AG Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
WO2013142999A1 (en) 2012-03-30 2013-10-03 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein
CA2916537C (en) 2013-07-03 2021-07-27 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups
EP3689881B1 (en) 2013-11-04 2022-01-12 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b
MX384292B (es) * 2013-12-06 2025-03-14 Eisai R&D Man Co Ltd Metodos utiles en la sintesis de analogos de halicondrina b.
KR102743950B1 (ko) 2015-05-07 2024-12-18 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 마크롤라이드의 합성에 유용한 마크로고리화 반응 및 중간체 및 기타 단편
EP3413887B1 (en) 2016-02-12 2021-04-07 Eisai R&D Management Co., Ltd. Intermediates in the synthesis of eribulin and related methods of synthesis
US11136335B2 (en) 2016-06-30 2021-10-05 Eisai R&D Management Co., Ltd. Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof

Also Published As

Publication number Publication date
IL273736B (en) 2021-03-25
JP6905041B2 (ja) 2021-07-21
BR112016012237B1 (pt) 2023-02-07
EP3505520A1 (en) 2019-07-03
US20170298078A1 (en) 2017-10-19
EP3077399A4 (en) 2017-05-10
IL273736A (en) 2020-05-31
US10030032B2 (en) 2018-07-24
SG11201604545XA (en) 2016-07-28
BR112016012237A2 (https=) 2017-08-08
MX376869B (es) 2025-03-07
CA2931788A1 (en) 2015-06-11
ES2723355T3 (es) 2019-08-26
EP3077399B1 (en) 2019-02-20
WO2015085193A1 (en) 2015-06-11
JP2016540752A (ja) 2016-12-28
CN105916861A (zh) 2016-08-31
US9695188B2 (en) 2017-07-04
US20160176895A1 (en) 2016-06-23
CN105916861B (zh) 2018-12-14
IL281275A (en) 2021-04-29
US20150158881A1 (en) 2015-06-11
IL281275B (en) 2021-12-01
MX2020004855A (es) 2021-07-08
JP2019031530A (ja) 2019-02-28
CA2931788C (en) 2022-05-24
IL265640A (en) 2019-05-30
RU2676486C1 (ru) 2018-12-29
MX2016006891A (es) 2017-06-12
JP2020059739A (ja) 2020-04-16
MX370611B (es) 2019-12-18
EP3077399A1 (en) 2016-10-12
US9303039B2 (en) 2016-04-05
IL245661A0 (en) 2016-06-30
US10450324B2 (en) 2019-10-22
IL265640B (en) 2020-04-30
JP6634135B2 (ja) 2020-01-22
MX2019011926A (es) 2019-11-18
MX384292B (es) 2025-03-14
SG10201805024YA (en) 2018-07-30
US20190010166A1 (en) 2019-01-10
JP6443812B2 (ja) 2018-12-26

Similar Documents

Publication Publication Date Title
HUE043088T2 (hu) Halikondrin B analógok szintézisében alkalmazható eljárások
IL269227B (en) Solid forms of treprostinil
LT3060041T (lt) Prostaciklino junginiai
DK3143161T3 (da) Nukleinsyresynteseteknikker
GB201421334D0 (en) Synthesis of aeizeolite
LT3080100T (lt) Lizinui specifinės demetilazės-1 inhibitoriai
DK2970336T3 (da) Tetrahydropyrrolothiazinforbindelser
EP2951139A4 (en) SYNTHESIS FROM 1,1,2,3-TETRACHLORPROPENE
HUE037048T2 (hu) Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására
DK2970389T3 (da) Farmaceutiske forbindelser
DK2954949T3 (da) Reaktor
PT2953948T (pt) Antagonistas de integrina fluorada
HRP20171890T1 (hr) Supstituirani imidazopiridazini
HUE053751T2 (hu) Eljárás iopamidol elõállítására
EP2945942A4 (en) Voriconazole IMMUNOASSAY
HRP20170247T1 (hr) Biciklični spojevi
IL240904A0 (en) Azetidinyloxyphenylpyrrolidine compounds
BR112016002104A2 (pt) método de síntese de 3-oxopent-4-enoil-coa
HRP20180618T1 (hr) Spojevi fluorfenilpirazola
DE102014221388B8 (de) Ladezustands-Berechungsvorrichtung
DK2947066T3 (da) Phenoxyalkylaminforbindelse
HUE063095T2 (hu) Eljárások pirimidinilciklopentán vegyületek elõállítására
PT2799426T (pt) Novo processo para a síntese de aminaftona
HRP20182110T1 (hr) Sastav spojeva tiakumicina
ITMI20130606A1 (it) Composti naftoeterodiazolici disostituiti